Iovance Biotherapeutics's three largest insider shareholders as of March 23, 2026 are Wayne P. Rothbaum (Director, 28.07Mn shares), Frederick G Vogt (Interim Ceo General Counsel, 529.54K shares), Merrill A Mcpeak (Director, 320.15K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Wayne P. Rothbaum | 0 | 28,067,333 | 20 Feb, 2024 | |
| Frederick G Vogt | Interim Ceo General Counsel | 529,538 | 0 | 06 Mar, 2026 |
| Merrill A Mcpeak | 320,150 | 0 | 20 Feb, 2024 | |
| Merrill A Mcpeak | 0 | 248,633 | 19 Sep, 2023 | |
| Raj K. Puri | Chief Regulatory Officer | 239,230 | 0 | 06 Mar, 2026 |
| Daniel Gordon Kirby | Chief Commercial Officer | 139,381 | 0 | 26 Feb, 2026 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 131,957 | 0 | 06 Mar, 2026 |
| Igor Bilinsky | Chief Operating Officer | 125,766 | 0 | 06 Mar, 2026 |
| Michael Weiser | 112,632 | 0 | 02 Jun, 2022 | |
| Jean-Marc Bellemin | Chief Financial Officer | 60,529 | 0 | 04 Jun, 2025 |
| Iain D. Dukes | 54,000 | 0 | 20 Feb, 2024 | |
| Ryan D Maynard | 7,500 | 0 | 14 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Corleen M. Roche | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Raj K. Puri | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Igor Bilinsky | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Finckenstein Friedrich Graf | Restricted Stock Units | A | 58,750 | $0.00 | 58,750 | D | A |
| 09 Mar, 2026 | Frederick G Vogt | Restricted Stock Units | A | 235,000 | $0.00 | 235,000 | D | A |
| 09 Mar, 2026 | Daniel Gordon Kirby | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 05 Mar, 2026 | Raj K. Puri | Common Stock | A | 39,059 | $0.00 | 257,590 | D | M |
| 05 Mar, 2026 | Frederick G Vogt | Common Stock | A | 62,493 | $0.00 | 556,293 | D | M |
| 05 Mar, 2026 | Finckenstein Friedrich Graf | Common Stock | A | 31,246 | $0.00 | 148,477 | D | M |
| 05 Mar, 2026 | Igor Bilinsky | Common Stock | A | 31,246 | $0.00 | 142,394 | D | M |
| 05 Mar, 2026 | Finckenstein Friedrich Graf | Common Stock | D | 16,520 | $4.58 | 131,957 | D | F |
| 05 Mar, 2026 | Frederick G Vogt | Common Stock | D | 26,755 | $4.58 | 529,538 | D | F |
| 05 Mar, 2026 | Raj K. Puri | Common Stock | D | 18,360 | $4.58 | 239,230 | D | F |
| 05 Mar, 2026 | Igor Bilinsky | Common Stock | D | 16,628 | $4.58 | 125,766 | D | F |
| 05 Mar, 2026 | Frederick G Vogt | Restricted Stock Units | D | 62,493 | $0.00 | 125,007 | D | M |
| 05 Mar, 2026 | Igor Bilinsky | Restricted Stock Units | D | 31,246 | $0.00 | 62,504 | D | M |
| 05 Mar, 2026 | Raj K. Puri | Restricted Stock Units | D | 39,059 | $0.00 | 78,131 | D | M |
| 05 Mar, 2026 | Finckenstein Friedrich Graf | Restricted Stock Units | D | 31,246 | $0.00 | 62,504 | D | M |
| 02 Mar, 2026 | Frederick G Vogt | Common Stock | A | 52,087 | $0.00 | 516,609 | D | M |
| 02 Mar, 2026 | Raj K. Puri | Common Stock | A | 5,470 | $0.00 | 221,329 | D | M |